BIO.News Newsletter

Two federal programs that have been driving small business innovation for 40 years are in danger of running out of money—we take a deep dive. Plus, bluebird bio’s big approval and what we need to do about the bees. (732 words, 3 minutes, 39 seconds)

Just when you think you can take a summer break, you learn that polio is circulating in the U.S. Here’s what we know—and how vaccination can prevent it. Plus, COVID-19 caused many to forget about Zika—but it’s reemerging as a risk. (635 words, 3 minutes, 10 seconds)

The bioplastics business is booming, with companies investing billions into biotech-derived plastic alternatives—we tell you about a few. Plus, August is Psoriasis Action Month, and the National Psoriasis Action Foundation has resources about the links to stress and mental health. (586 words, 2 minutes, 55 seconds)

The House passed the Inflation Reduction Act on Friday, sending anti-science drug price controls to POTUS for signature. Meanwhile, inflation seems to be easing, but food prices are still high. Luckily, we have biotech to address some of the root causes. (548 words, 2 minutes, 44 seconds)

The House returns from recess to vote on drug price controls. Meanwhile, it’s National Immunization Awareness Month, a chance to highlight how vaccines changed the world—and how misinformation and policy (like price controls) could thwart progress. Plus, an emerging zoonotic disease is a reminder of the need for a One Health approach and modern animal biotech regulations. (836 words, 4 minutes, 10 seconds)

A new analysis of Texas data shows—surprise, surprise—PBMs don’t pass on rebates and savings from drug makers to patients. Plus, we look at how biotech is resurrecting what’s considered Latin America’s oldest beer. Meanwhile, we’re keeping an eye on the House, which could vote on price controls as soon as tomorrow. (650 words, 3 minutes, 15 seconds)

A new study confirms that climate change is making infectious disease worse—and we’re seeing this play out in real time right here in the U.S. Meanwhile, the FDA’s EUA yesterday will make more monkeypox vaccine doses available. (761 words, 3 minutes, 48 seconds)

Pfizer will acquire sickle cell pioneer Global Blood Therapeutics, the sickle cell pioneer led by BIO Vice Chair Dr. Ted Love. We have the details, plus a look at how climate change is playing a role in the increase in Lyme disease. (859 words, 4 minutes, 17 seconds)

The Senate passed innovation-killing drug price controls yesterday—here’s what you need to know about the legislation and what’s expected to happen next. Plus, with drought ravaging the U.S., we look at biotech solutions and the policy needed to deploy them. (823 words, 4 minutes, 6 seconds)

It’s not too late to take action on drug price controls—we tell you why (and how). Plus, the busy summer continues with the Biden administration declaring monkeypox a Public Health Emergency and the FDA releasing much-needed educational materials on GMOs. (659 words, 3 minutes, 17 seconds)